Episodes

  • POEMS Syndrome
    Nov 17 2026

    POEMS syndrome is a paraneoplastic disorder driven by clonal plasma cells producing excess VEGF and proinflammatory cytokines. Endocrinopathies affect the majority of patients, most commonly primary or secondary hypogonadism, adrenal insufficiency, and hypothyroidism. We review the essential diagnostic criteria, distinguishing features from CIDP, serum free light chain evaluation, and systemic therapies targeting the underlying clone to resolve multi-organ dysfunction.


    Show More Show Less
    23 mins
  • Post Hydrocortisone "Crash"
    Nov 16 2026

    Post-hydrocortisone crashes stem from rapid clearance kinetics, where steep trough levels trigger rebound ACTH surges, hypocortisolemic symptoms, or perceived withdrawal despite adequate daily cumulative dosing. We break down the clinical distinction between genuine under-replacement and pharmacokinetic troughs, strategies for dose fractionation, circadian curve optimization, and the diagnostic utility of switching to dual-release formulations or longer-acting glucocorticoids.


    Show More Show Less
    15 mins
  • Nuanced Hyperthyroidism Workup
    Nov 13 2026

    Differentiating thyrotoxicosis etiologies requires moving beyond suppressed TSH to evaluate free T3 to free T4 ratios, TRAb titers, and radioactive iodine uptake kinetics. We break down distinguishing high-uptake states like Graves disease and toxic adenomas from destructive thyroiditis, the utility of Doppler ultrasound, and targeted management strategies across antithyroid drug selection, radioactive iodine, and surgical indications.


    Show More Show Less
    26 mins
  • The Oral Overnight Metyrapone Test
    Nov 12 2026

    The overnight metyrapone test interrogates hypothalamic-pituitary-adrenal reserve via 11-beta-hydroxylase blockade, circumventing cosyntropin false-negatives in acute corticotroph injury where adrenocortical atrophy is absent. Interpretation demands sequential analysis: post-dose cortisol below 5 ug/dL confirms enzyme inhibition, while 11-deoxycortisol above 7 ug/dL verifies reserve. Levels between 7 to 10 ug/dL require Bayesian pretest calibration. Testing established insufficiency risks precipitating adrenal crisis.

    Show More Show Less
    24 mins
  • Thyroid Radioactive Iodine Uptake Patterns
    Nov 11 2026

    Radioactive iodine uptake differentiates de novo hyperthyroidism from destructive or factitious thyrotoxicosis. Diffusely elevated tracer accumulation confirms Graves disease driven by thyrotropin-receptor antibodies, whereas focal autonomy denotes toxic adenoma or toxic multinodular goiter with extranodular suppression. Conversely, suppressed or absent uptake indicates destructive thyroiditis, exogenous hormone exposure, or recent iodine contamination, shifting clinical management from thionamides toward symptomatic beta-blockade.

    Show More Show Less
    27 mins
  • Adrenergic Symptoms Differentials
    Nov 10 2026

    This episode reviews the differential diagnosis of paroxysmal adrenergic symptoms, contrasting sympathoadrenal hyperreactivity with catecholamine-secreting neuroendocrine tumors. We analyze the diagnostic utility and pre-test confounding factors of plasma versus fractionated urinary metanephrines, evaluate concurrent features of thyrotoxicosis, carcinoid syndrome, and mast cell activation, and outline evidence-based alpha-blockade protocols prior to surgical or medical intervention.


    Show More Show Less
    25 mins
  • POTS and endocrine mimics
    Nov 9 2026

    This episode evaluates postural orthostatic tachycardia syndrome, exploring neuroendocrine and autonomic dysregulation, including hyperadrenergic phenotypes and volume depletion. We examine diagnostic tilt-table criteria, the crucial exclusion of primary endocrine mimics such as pheochromocytoma and adrenal insufficiency, and evidence-based management strategies spanning fludrocortisone, nonselective beta-blockers, alpha-1 agonists, and structured physical reconditioning.


    Show More Show Less
    16 mins
  • Subclinical Hyperthyroidism
    Nov 6 2026

    This episode examines subclinical hyperthyroidism, characterized by suppressed serum TSH alongside normal free thyroxine and triiodothyronine. We analyze etiology differentiation between autonomous nodular disease and Graves disease, risk stratification for atrial fibrillation and accelerated bone loss, and guideline thresholds for initiating antithyroid pharmacotherapy or definitive ablation in older adults and postmenopausal patients.


    Show More Show Less
    23 mins